Delivery Order SPE2DR25D3012-SPE2DR26F4D4D
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This contract, issued under a firm fixed-price delivery order structure, carries a ceiling value of $1,038.01 and is scheduled for completion by December 11, 2025. The award represents a non-competitive set-aside and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $2,995.68 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of December 4, 2025. The award was issued on December 3, 2025, with performance to take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency (DLA) awarded a $2,776.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. The contract, which is a non-set-aside competitive award, is scheduled for completion by December 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging. This contract, valued at $2,497.20 with a firm fixed price structure, represents a small delivery order with an ultimate completion date of December 16, 2025. The award carries no set-aside designation, indicating it was competitively awarded through open procurement processes. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units, with a ceiling value of $2,081.00 and a firm fixed price structure. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,016.96 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. The award, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,298.88 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This contract, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a firm fixed price delivery order with no set-aside designation. The award was competitively executed and the place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,751.97 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 on December 11, 2025, with a completion date of December 12, 2025. This non-competitive delivery order represents a firm fixed price transaction performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a delivery order valued at $2,545.85 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s. This order, issued on November 20, 2025, with completion targeted for November 21, 2025, represents a firm fixed price delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded without set-aside designations, reflecting open...
- The Defense Logistics Agency awarded a $5,694.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10-count) on December 2, 2025, with completion due by December 3, 2025. This competitive award, which received no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4D4DDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for Oseltamivir Phosphate 75 mg capsules in unit dose packaging. The contract, valued at $1,099.36, represents a firm fixed price delivery order with an ultimate completion date of December 16, 2025. This award was not set aside for small business or other socioeconomic categories and was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains, enabling it to fulfill diverse federal procurement requirements. This delivery order for antiviral medication supports DLA's mission to supply pharmaceutical products to military healthcare programs worldwide. As a prime contractor under the DLA Troop Support Medical vehicle, AmerisourceBergen continues to demonstrate its capability to meet federal procurement standards through competitive procurement processes and reliable delivery of essential medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/14/25 |